Pascale was appointed to the board in August 2017. She brings more than two decades of global healthcare management experience to the board and most recently served as executive vice president, global diabetes and cardiovascular at Sanofi. During her tenure with the company, she launched multiple medicines across three continents and strengthened the pipeline through licensing and partnerships.
Prior to joining Sanofi, Pascale served more than 17 years at GE Healthcare where, in her final role as president and chief executive officer of its medical diagnostics business, she ran a $2 billion integrated pharmaceutical organization that encompassed research and development through commercial.
Pascale received her Master of Business Administration in Economics and Marketing from INSEAD and her Master of Science in Biochemistry from INSA Lyon. She currently serves on the board of directors for Fresenius Medical Care AG & Co. KGaA, a world leader in dialysis, Savencia SA, a food and dairy company; and Regulus Therapeutics, a biotechnology company focused on the discovery and development of microRNA therapeutics.